Sinaptica Therapeutics
Founded 2021 · 19 employees on LinkedIn · 5 known investors
Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
Founders & leadership
Sinaptica Therapeutics was founded in 2021 by Scientific Co-Founder (University of Ferrara) and Scientific Co-Founder (Harvard Medical School).
SC
Scientific Co-Founder (University of Ferrara)Scientific Co-Founder
SC
Scientific Co-Founder (Harvard Medical School)Scientific Co-Founder
Investors · 5
Founder mafia
2 people who came through Sinaptica Therapeutics went on to found or lead other companies.
In the news
Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - BioSpacebiospace.com · Sep 2026Frequently asked questions
- What does Sinaptica Therapeutics do?
- Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
- Who founded Sinaptica Therapeutics?
- Sinaptica Therapeutics was founded by Scientific Co-Founder (University of Ferrara), Scientific Co-Founder (Harvard Medical School) in 2021.
- Who are Sinaptica Therapeutics's investors?
- Sinaptica Therapeutics's investors include Bootstrap Venture Partners, Healthtech Capital, NW Angel, Sony Ventures Corporation, Time Zero Capital.

